MA
UTMD icon

Minerva Advisors’s Utah Medical Products UTMD Stock Holding History

Minerva Advisors’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.46M Hold
93,615
– – 4.08% 7
2026
Q1 		$5.8M Hold
93,615
– – 3.75% 9
2025
Q4 		$5.24M Buy
93,615
+557
+0.6% +$32.3K 3.5% 10
2025
Q3 		$5.86M Hold
93,058
– – 3.72% 9
2025
Q2 		$5.27M Buy
93,058
+6,156
+7% +$335K 3.45% 10
2025
Q1 		$4.87M Buy
86,902
+8,513
+11% +$510K 3.46% 8
2024
Q4 		$4.82M Buy
78,389
+36,061
+85% +$2.33M 2.82% 12
2024
Q3 		$2.82M Buy
42,328
+34,794
+462% +$2.36M 1.63% 19
2024
Q2 		$503K Buy
+7,534
New +$513K 0.34% 36

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Minerva Advisors's UTMD Position: Q2 2026 in Review

Minerva Advisors held its Utah Medical Products (UTMD) position steady in Q2 2026 at 93,615 shares worth $6.46M. The position accounts for 4.08% of the portfolio, ranked #7.

Minerva Advisors first reported a position in UTMD in Q2 2024 and has held it in 9 quarters since. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • Minerva Advisors held 93,615 shares of Utah Medical Products worth $6.46M as of Q2 2026.
  • Minerva Advisors left its Utah Medical Products share count unchanged in Q2 2026.
  • Utah Medical Products made up 4.08% of Minerva Advisors's portfolio in Q2 2026, its #7 holding.
  • Minerva Advisors first reported a position in Utah Medical Products in Q2 2024 and has held it in 9 quarters since.
  • 114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Minerva Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.